GNLX- Genelux Corporation

Insider activity in GNLX over the last quarter tilts toward selling: insiders offloaded a net 58,732 shares worth roughly $159K.

Classified under Biotechnology (Health Care sector), GNLX's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Zindrick Thomas	1.23M	$3.27M	-
Dir	Thomas John	501.2K	-	-
Other	Cappello Joseph	318.5K	$872.9K	-
CFO	Pulisic Matthew	278.9K	-	-
Other	Litten Jason	275.0K	-	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 31, 2026	Yu Yong77	Chief Scientific Officer	Sell	9,683	$2.75	$26,658.27	-3.6%	-	-
Aug 31, 2026	Zindrick Thomas	President And CEO	Sell	34,463	$2.67	$91,899.04	-2.7%	-	-
Aug 31, 2026	Cappello Joseph47	Chief Technical Officer	Sell	10,257	$2.74	$28,112.39	-3.1%	-	-
Aug 4, 2026	Zindrick Thomas	President And CEO	Sell	3,023	$2.95	$8,905.46	-0.2%	-	-
Aug 4, 2026	Yu Yong77	Chief Scientific Officer	Sell	653	$2.94	$1,922.04	-0.2%	-	-
Aug 4, 2026	Cappello Joseph47	Chief Technical Officer	Sell	653	$2.95	$1,924.20	-0.2%	-	-
Jul 1, 2026	Smither John W65	Director	Sell	12,000	$2.91	$34,898.40	-11.6%	-	-
Jun 3, 2026	Smalling Ralph54	Head Of Regulatory	Sell	192	$2.93	$562.56	-0.3%	-	-
Jun 1, 2026	Thomas John77	Director	Sell	10,000	$2.98	$29,801.00	-2.1%	-	-
May 11, 2026	Zindrick Thomas	President And CEO	Sell	2,798	$2.94	$8,225.56	-0.5%	-	-